Fig. 1: Dot plots showing cerebrospinal fluid (CSF) amyloid precursor protein (APP), glial cell line-derived neurotrophic factor (GDNF), and neural cell adhesion molecule (NCAM)-1 levels in four diagnostic groups. | Translational Psychiatry

Fig. 1: Dot plots showing cerebrospinal fluid (CSF) amyloid precursor protein (APP), glial cell line-derived neurotrophic factor (GDNF), and neural cell adhesion molecule (NCAM)-1 levels in four diagnostic groups.

From: Cerebrospinal fluid neuroplasticity-associated protein levels in patients with psychiatric disorders: a multiplex immunoassay study

Fig. 1

CSF APP level was significantly lower in patients with schizophrenia and those with BD than in healthy controls (a p < 0.05). CSF GDNF level in patients with schizophrenia and CSF NCAM-1 level in patients with BD levels were significantly lower than in healthy controls, respectively (b, c p < 0.05). Horizontal lines in the dot plots show mean values. BD bipolar disorder, MDD major depressive disorder.

Back to article page